These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20960796)

  • 1. [17alpha-Hydroxyprogesterone].
    Shimizu Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():371-3. PubMed ID: 20960796
    [No Abstract]   [Full Text] [Related]  

  • 2. [17alpha-hydroxyprogesterone].
    Shimizu Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():344-6. PubMed ID: 16149525
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X; Zhou J; Ye J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G; García de la Rosa I; González Reyes EC; Rubio Torres A; Quintana Guerra JM; Hernández Marín M; Pérez Mora PL; Feal Carballo S; Lafita Delfino Y; Pupo Infante M; Castells Martínez EM; Rosabal Poloshkov A; Hernández Pérez L
    Clin Chim Acta; 2018 Oct; 485():311-315. PubMed ID: 30006291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience.
    Mikami A; Fukushi M; Oda H; Fujita K; Fujieda K
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():100-2. PubMed ID: 11400741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 3. An enzyme-linked immunosorbent assay for dried blood 17 alpha-hydroxyprogesterone].
    Fukushi M; Arai O; Mizushima Y; Takasugi N; Fujieda K; Matsuura N
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):113-22. PubMed ID: 3494638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
    Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and diagnosis of congenital adrenal hyperplasia in Basilicata (Italy).
    Cordova RA; Vignola G
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():103. PubMed ID: 11400742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
    Brossaud J; Barat P; Fagour L; Corcuff JB
    Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of serum 17 alpha-hydroxyprogesterone analysis in endocrine tests of the adrenal cortex].
    Watanabe F
    Nihon Rinsho; 1989 Dec; 48 Suppl():1231-4. PubMed ID: 2621850
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of adrenocortical tumor in a neonate by detection of elevated blood 17-hydroxyprogesterone measured as a routine neonatal screening for congenital adrenal hyperplasia: a case report.
    Hishiki T; Kazukawa I; Saito T; Terui K; Mitsunaga T; Nakata M; Matsuura G; Minagawa M; Kohno Y; Yoshida H
    J Pediatr Surg; 2008 Oct; 43(10):e19-22. PubMed ID: 18926198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving neonatal screening for congenital adrenal hyperplasia.
    Speiser PW
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3685-6. PubMed ID: 15292288
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study.
    Chu SY; Tsai WY; Chen LH; Wei ML; Chien YH; Hwu WL
    J Formos Med Assoc; 2002 Oct; 101(10):691-4. PubMed ID: 12517042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS; Allen DB; Hoffman GL
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital adrenal hyperplasia: family screening using 17-hydroxyprogesterone (17-OHP) response to adrenocorticotropin (ACTH).
    Soliman AT; Omar M; Al Ali M; Rizk MM; Nasr I; AbolMagd M
    J Trop Pediatr; 2006 Apr; 52(2):147-8. PubMed ID: 16258004
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.
    Terai I; Yamano K; Ichihara N; Arai J; Kobayashi K
    Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F179-83. PubMed ID: 10525019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of 17alpha-hydroxypregnenolone and 17alpha-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS.
    Higashi T; Nishio T; Uchida S; Shimada K; Fukushi M; Maeda M
    J Pharm Biomed Anal; 2008 Sep; 48(1):177-82. PubMed ID: 18571354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for congenital adrenal hyperplasia.
    van der Kamp HJ; Wit JM
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U71-5. PubMed ID: 15554889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timely neonatal screening.
    Dhondt JL; Farriaux JP
    J Med Screen; 1999; 6(2):112-3. PubMed ID: 10444733
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha-hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave-assisted silylation.
    Deng C; Ji J; Zhang L; Zhang X
    Rapid Commun Mass Spectrom; 2005; 19(20):2974-8. PubMed ID: 16178052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.